Nu-Med Plus, Inc. (NUMD)
Nu-Med Plus, Inc. operates in the Medical - Devices industry of the Healthcare sector, headquartered in Port Jefferson, NY, US. The stock last traded at $0.02, down 17.39% on the session, giving a market capitalisation of $1.3M. On trailing twelve-month figures it carries a trailing P/E of -25.33, a net margin of 0.0%. Its beta of -2.31 implies it has historically moved less than the broad market.
Nu-Med Plus, Inc. is a global medical technology firm dedicated to the innovation, refinement, and commercialization of various medical instruments. The company's offerings include a diverse array of nitric oxide delivery systems, such as specialized units for hospital environments, clinical applications, and research settings, alongside a mobile, rechargeable device designed for portable nitric oxide gas administration. Serving a broad spectrum of healthcare entities, its primary clients consist of hospitals, integrated health systems, and the wider medical professional community. Nu-Med Plus, Inc. was founded in 2011 and maintains its corporate headquarters in Salt Lake City, Utah.
Nu-Med Plus, Inc. is most often compared with the following Healthcare names: